Calithera Biosciences (NASDAQ:CALA) Stock Price Breaks Above Fifty Day Moving Average – What’s Next?

Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Calithera Biosciences shares last traded at $0.00, with a volume of 0 shares changing hands.

Calithera Biosciences Price Performance

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc was a clinical-stage biopharmaceutical company focused on developing small-molecule therapies that target cancer metabolism. The company sought to exploit metabolic dependencies in tumor cells to create treatments for cancer, with research programs designed for use both as standalone therapies and in combination with existing medicines.

Calithera’s lead investigational product was telaglenastat (also known as CB-839), an oral inhibitor of glutaminase, an enzyme involved in glutamine metabolism.

Featured Articles

• Five stocks we like better than Calithera Biosciences
• Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
• Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
• Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
• Why Wall Street Expects Even More From SanDisk After Its 575% Rally